Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

38.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

5.6K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure Pattern Determines Methamphetamine-Induced Right Ventricular Dysfunction and Vascular Remodeling.

Comprehensive Physiology·2026
Same author

Metabolotheranostics of pancreatic cancer by targeting choline, glutamine, and glucose transporters with photoimmunotherapy.

Npj imaging·2026
Same author

Multiorgan transcriptomics and circulating extracellular vesicle profiling reveal age-dependent systemic vulnerability to isoflurane anesthesia and surgery.

GeroScience·2026
Same author

Transformative microsystems for Cancer Diagnosis, treatment monitoring, and clinical integration: Outcomes from an NCI Workshop.

Journal of the National Cancer Institute·2026
Same author

Fingerprinting the Metabolic and Lipidomic Landscapes of Pancreatic Ductal Adenocarcinoma with MALDI Imaging.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Functional effects of EpCAM N-glycosylation in MDA-MB-468 breast cancer cells.

Scientific reports·2026

Related Experiment Video

Updated: Mar 18, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K

Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation,

Maria Dung Cao1,2,3, Menglin Cheng3, Asif Rizwan3

  • 1Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.

NMR in Biomedicine
|July 1, 2016
PubMed
Summary

Silencing glycerophosphodiesterase genes (GDPD5 and GDPD6) in breast cancer cells increases glycerophosphocholine (GPC) levels. GDPD5 silencing reduced cell viability and invasion, suggesting potential for novel breast cancer therapies.

Keywords:
GDPD5GDPD6breast cancercholine phospholipid metabolismgene targeted treatment

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.5K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K

Related Experiment Videos

Last Updated: Mar 18, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.5K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.7K

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Abnormal choline phospholipid metabolism is linked to cancer development and progression.
  • Glycerophosphodiesterase (GDPD) enzymes play a role in regulating cellular choline metabolites.

Purpose of the Study:

  • To investigate the impact of silencing GDPD5 and GDPD6 genes on choline phospholipid metabolism in breast cancer cells.
  • To evaluate the effects of GDPD5 and GDPD6 gene silencing on breast cancer cell viability, proliferation, migration, and invasion.

Main Methods:

  • Small interfering RNA (siRNA) was used to silence GDPD5 and GDPD6 genes in MCF-7 and MDA-MB-231 breast cancer cell lines.
  • Levels of glycerophosphocholine (GPC), phosphocholine, and free choline were measured.
  • Cell viability, apoptosis (DNA laddering), migration, and invasion assays were performed.

Main Results:

  • Silencing GDPD5 and GDPD6 significantly increased GPC levels, with GDPD6 silencing showing a more profound effect.
  • GDPD5 silencing decreased cell viability in MCF-7 cells, while GDPD6 silencing had no significant effect on viability in either cell line.
  • Both GDPD5 and GDPD6 silencing reduced cell migration and invasion in MDA-MB-231 cells, with GDPD5 silencing having a more pronounced effect.

Conclusions:

  • GDPD6 silencing is a more potent regulator of GPC levels in breast cancer cells compared to GDPD5.
  • GDPD5 silencing exhibits more severe effects on cell viability, migration, and invasion than GDPD6 silencing.
  • Targeting GDPD5 and GDPD6, individually or in combination, presents a potential novel therapeutic strategy for breast cancer.